Dr. Eric Kirshenbaum

Dr. Eric Kirshenbaum
Dr. Eric Kirshenbaum completed his medical education at the University of Illinois Chicago, residency in urology at Loyola University Medical Center, and fellowship in men's health and reconstructive urology at Loyola University Medical Center under the mentorship of Dr. Chris Gonzlalez and Dr. Kevin McVary. He specializes in men's health and reconstructive urology with an emphasis on urethral stricture disease, erectile dysfunction, male incontinence, prosthetic surgery, benign prostatic enlargement (BPH), laser surgery, urologic cancers, telemedicine, and robotic surgery. Throughout his training, he published extensively on the topics of men's health and reconstructive urology. In 2019 he was admitted as a member of The Society of Genitourinary Reconstructive Surgeons and is an active member of the American Urologic Association (AUA). He serves as a board member of the AUA telemedicine task force and has a particular interest in advancing the field of telemedicine. Dr. Kirshenbaum pursued a career in urology in order to improve the lives of his patients by offering solutions to their life-altering urologic problems. He has dedicated his career to restoring functions lost with aging, trauma, and cancer treatments. "My pursuit of medicine has always focused on impacting those around me in a positive way. I am passionate about helping others in their most vulnerable moments and coming up with patient-centered solutions"

Languages Spoken:


Medical School:

University of Illinois at Chicago College of Medicine, Chicago, Illinois United States Doctor of Medicine


Loyola University Medical Center, Chicago, Illinois United States Residency, Urology


Loyola University Medical Center, Chicago, Illinois United States Residency, Urology


University of Michigan, Ann Arbor, Michigan United States Bachelor of Science, Biology

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only